Snakebite envenoming is a neglected public health challenge of compelling importance in
many regions of the world, particularly sub-Saharan Africa, Asia, Latin America and Papua …

Venomous snakebite is considered the single most important cause of human injury from
venomous animals worldwide. Coagulopathy is one of the commonest important systemic …

Snakebites represent an important neglected public health problem in many developing
countries. There is a lack of epidemiological data, which would be very useful for the …

The Handbook of Venoms and Toxins of Reptiles offers" one-stop shopping" to all biologists,
biochemists, toxicologists, physicians, clinicians, and epidemiologists, and informed …

The development of snake antivenoms more than a century ago should have heralded
effective treatment of the scourge of snakebite envenoming in impoverished, mostly rural …

Snake antivenoms are formulations of immunoglobulins, or immunoglobulin fragments,
purified from the plasma of animals immunized with snake venoms. Their therapeutic …

The parenteral administration of antivenoms is the cornerstone of snakebite envenoming
therapy. Efforts are made to ensure that antivenoms of adequate efficacy and safety are …

The concept of antivenoms was first developed by Henry Sewall in 1887 when he
demonstrated that pigeons could be immunized against the effects of pygmy rattlesnake …

The first—and only—authoritative guide to the snakes of Central and Western Africa.
Nobody knows exactly how many snake species live in the biodiversity hotspots of Western …

Animal-derived antivenoms constitute the mainstay in the therapy of snakebite envenoming.
Antivenoms are manufactured by immunizing animals, usually horses, with venoms from a …